Ultrasound imaging for the rheumatologist XLIII. Ultrasonographic evaluation of shoulders and hips in patients with polymyalgia rheumatica: A systematic literature review by Sakellariou, G. et al.
11Chair and Division of Rheumatology, 
IRCCS Polyclinic San Matteo 
Foundation, Pavia, Italy; 
2Rheumatology Unit, Department of 
Internal Medicine, Sapienza University 
of Rome, Policlinico Umberto 1°, Rome, 
Italy; 3Rheumatology Unit, University of 
Pisa, Italy; 4Rheumatology Clinic, 
Polytechnic University delle Marche, 
Jesi, Italy.
Garifallia Sakellariou, MD
Annamaria Iagnocco, MD
Lucrezia Riente, MD
Fulvia Ceccarelli, MD, PhD
Linda Carli, MD
Luca Di Geso, MD
Andrea Delle Sedie, MD
Emilio Filippucci, MD
Carlomaurizio Montecucco, MD, Prof.
Please address correspondence to: 
Dr Garifallia Sakellariou, 
Divisione di Reumatologia, 
Fondazione IRCCS Policlinico 
San Matteo, 
Viale Camillo Golgi 19, 
2710 Pavia, Italy. 
E-mail: filiciasak@gmail.com
Received on January 7, 2013; accepted in 
revised form on January 14, 2013.
Clin Exp Rheumatol 2013; 31: 1-7.
© Copyright CLINICAL AND 
EXPERIMENTAL RHEUMATOLOGY 2013.
Key words: polymyalgia rheumatica, 
ultrasonography, diagnosis
Competing interests: none declared.
ABSTRACT
Objective. Musculoskeletal ultra-
sonography (US) has lately been ap-
plied to patients with polymyalgia 
rheumatica for the examination of 
shoulders and hip, and included in 
the 2012 PMR classification criteria. 
We aimed to perform a comprehensive 
overview of the literature on this topic 
with a systematic review.
Methods. We searched PubMed, Em-
base, the Cochrane library and the 
proceedings from EULAR and ACR 
congresses (2011–2012). We included 
studies evaluating patients with con-
firmed or suspected PMR, undergo-
ing US of shoulders and/or hips. The 
diagnosis of PMR could be based on 
expert opinion or diagnostic criteria. 
Cohort, case-control, diagnostic accu-
racy studies and case-series were eli-
gible for inclusion. The features of the 
included studies were presented. When 
available, sensitivities and specificities 
were calculated for primary studies.
Results. Out of 1736 papers identified 
by our search, 13 articles and 1 abstract 
were finally included in the review. 
Eight studies focused on shoulder US, 
1 on hip US, 4 on both. Studies were ex-
tremely variable in terms of population, 
US examination, reference standard 
and control population. In general, at 
the shoulder, pathological bilateral US 
findings in most studies were more prev-
alent in patients with PMR compared to 
controls. When sensitivity and specifi-
city could be calculated, bilateral find-
ings were more sensitive. Notably, less 
information was available on hip US.
Conclusion. US (especially in shoul-
der examination) is confirmed to be a 
potentially useful instrument to inte-
grate clinical information in the man-
agement of patients with PMR. Its ad-
ditional value in conjunction with the 
new classification criteria should be 
further tested.
Introduction
Polymyalgia rheumatica (PMR) is a 
relatively frequent inflammatory dis-
ease (1) involving elderly patients that 
determines inflammatory pain at scapu-
lar and pelvic girdles (2). The disease 
has a characteristic clinical presenta-
tion, however, diagnosis is not always 
straightforward at the first evaluation, 
with elderly-onset rheumatoid arthritis 
(EORA) representing the most difficult 
differential diagnosis (3), but also with 
possible secondary forms (4). Several 
markers  (5-7) have been proposed for 
differential diagnosis, without satisfac-
tory results, and this has remained an 
unresolved issue.
In fact, a single reliable reference stand-
ard for the diagnosis of PMR has not 
been found, and often a definite diag-
nosis can emerge only after a period of 
follow-up, also evaluating the response 
to corticosteroids (8-10). 
Due to the subsequent difficulties in 
including patients in clinical trials, in 
2012 the ACR and EULAR proposed 
new classification criteria for PMR (11, 
12). The new criteria were developed 
based on expert opinion, but they were 
afterwards tested in an observational 
study performed ad hoc. Patients were 
included if they presented with new 
onset bilateral shoulder pain, they were 
over 50 years old and they had not been 
previously treated with corticosteroids; 
the diagnosis of PMR had to be con-
firmed by the physician. Patients were 
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treated according to a standardised cor-
ticosteroid-based therapeutic protocol. 
The prospective study also included a 
control population of patients without 
PMR but with similar presentation. Pa-
tients were followed for 26 weeks and 
at each visit the response to corticoster-
oids was evaluated.
In the last decade musculoskeletal ul-
trasonography (US) has been increas-
ingly used in rheumatology (13-17), 
and several studies have tested its value 
also in cohorts of PMR patients, focus-
ing in particular on hip and shoulder 
assessment  (18-20). US has been used 
for both diagnostic purposes and fol-
low-up (21).
For this reason, patients enrolled in the 
observational study for the develop-
ment of the criteria underwent shoul-
der and hip US. All the examined US 
abnormalities were helpful to distin-
guish between patients with PMR and 
controls without rheumatoid arthritis 
(RA), while only the involvement of 
at least one shoulder and one hip was 
taken to be a distinction between PMR 
and RA (9).
US was finally included in the criteria 
therefore included in the final set of 
classification criteria; the criteria can 
be applied using only clinical features, 
however, the addition of US slightly 
improves their performance.
Recently, a systematic review on the 
application of all imaging modalities in 
PMR has been published (22). This re-
view also took into account US, but was 
not specifically focused on that and the 
search was last carried in 2010, before 
the presentation of the new criteria.
We wanted therefore to perform a sys-
tematic literature search specifically 
focused on shoulder and hip US in 
PMR, evaluating the prevalence of US 
abnormalities in patients with PMR and 
their diagnostic value. We also aimed 
to evaluate the usefulness of US for the 
follow-up of PMR patients.
Methods
A search strategy based on terms relat-
ed to PMR, EORA and US was devel-
oped. The search was meant to be quite 
broad, in order to be as sensitive rather 
than specific (Table I). We searched 
MEDLINE (PubMed), Embase and 
Cochrane Central, the search was last 
carried out on October 9th 2012. Fur-
thermore, we manually screened the 
proceedings from the ACR and EU-
LAR congresses (2011–2012) and the 
references of the included studies to 
look for additional studies. The search 
was limited to humans, but no language 
or publication restrictions were applied. 
Data were extracted using a standard-
ised form. The risk of bias of the studies 
was evaluated by the Newcastle-Ottawa 
scale for case-control or observational 
studies, when appropriate (23).
The target population was patients with 
a diagnosis or suspicion of PMR; the in-
dex test was US of the shoulders and/or 
of the hips. To test diagnostic accuracy, 
the pre-specified reference standards 
were expert opinion, definite diagnos-
tic/classificative criteria or response to 
glucocorticoids (24); diagnostic accu-
racy, retrospective or prospective co-
hort studies, case-control studies and 
case series were eligible for inclusion. 
When available, data on diagnostic ac-
curacy were extracted in 2x2 tables to 
estimate sensitivity and specificity of 
Table I. Search strategy.
PubMed #1”Ultrasonography”[Mesh]
 #2 “ultrasonography”
 #3 “ultrasonograph*”
 #4 “ultrasound”
 #5 #1 OR #2 OR #3 OR #4
 #6 “Polymyalgia Rheumatica”[Mesh]
 #7 “polymyalgia”
 #8 “polymyalgia rheumatica”
 #9 “polymyalg*”
 #10 #6 OR #7 OR #8 OR #9
 #11 “Arthritis, Rheumatoid”[Mesh]
 #12 “Arthritis, Rheumatoid”[Mesh]
 #13 “rheumatoid”
 #14 #11 OR #12 OR #13
 #15 “Aged, 80 and over”[Mesh]
 #16 “Middle Aged”[Mesh]
 #17 #15 OR #16
 #18 #14 AND #17
 #19 #10 AND #18
Embase 1’polymyalgia rheumatica’/de OR ‘polymyalgia rheumatica’ OR ‘polymyalgia’ OR ‘pol-
ymyalgic’ AND [embase]/lim
 2’rheumatoid arthritis’/exp OR ‘rheumatiod arthritis’ OR ‘rheumatoid’ AND [embase]/
lim
 3’middle aged’/exp OR ‘aged’/exp
 4 AND/2-3
 5 OR/1-4
 6 ‘echography’/exp OR ‘ecography’ OR ‘ultrasonography’ OR ‘ultrasound’ OR ‘ultra-
sonographic’
 7 AND/5-6
Cochrane #1 MeSH descriptor: [Ultrasonography] this term only
 #2 “ultrasonography”:ti,ab,kw  
 #3 “ultrasound”:ti,ab,kw  
 #4 ultrasonograph*:ti,ab,kw  
 #5 #1 or #2 or #3 or #4  
 #6 MeSH descriptor: [Arthritis, Rheumatoid] this term only
 #7 rheumatoid arthritis”:ti,ab,kw  
 #8 “rheumatoid”  
 #9 MeSH descriptor: [Aged] this term only
 #10 AGED, 80 and OVER:ti,ab,kw  
 #11 #9 or #10 
 #12 #6 or #7 or #8 
 #13 #11 and #12 
 #14 MeSH descriptor: [Polymyalgia Rheumatica] this term only
 #15 “polymyalgia rheumatica”:ti,ab,kw  
 #16 polymyalg*:ti,ab,kw  
 #17 “polymyalgia”:ti,ab,kw  
 #18 #14 or #15 or # 16 or #17 
 #19 #18 or #13 
 #20 #5 and #19
3IMAGINGUltrasonography in polymyalgia rheumatica / G. Sakellariou et al.
each US finding in primary studies. We 
focused on the diagnostic accuracy of 
the US findings that were included in 
the classification criteria: glenohumeral 
(GH) and coxofemoral (CF) synovitis, 
tenosynovitis of the long head of the bi-
ceps tendon (LHBT) and subacromial/
subdeltoid (SAD) bursitis, trochanteric 
bursitis. When sufficient data to calcu-
late sensitivity and specificity were pre-
sented, forest plots showing sensitivi-
ties and specificities for single US ab-
normalities of the primary studies were 
constructed using Review Manager 5 
(The Nordic Cochrane Centre, The Co-
chrane Collaboration, Copenhagen).
Results
The search strategy identified 1736 
records. Figure 1 shows the selection 
process that finally led to the inclu-
sion of 13 studies (12 full-text papers 
(18-21, 25-32) and 1 abstract (33)), in 
accordance with the selection criteria 
described in the methods section. The 
search retrieved also the systematic 
review we mentioned above (19). One 
study was excluded because, although 
based on shoulder US, the attention 
was focused on the deltoid fascia, that 
was found to be thicker in patients with 
PMR compared to healthy controls and 
to decrease after corticosteroid treat-
ment (34). The median (interquartile 
range, IQR) value of the Newcastle Ot-
tawa Scale was 6 (5, 6). In particular, 
items related to comparability were un-
satisfactory in most studies.
At first sight, there was a relevant de-
gree of variability among the studies. 
They were performed in periods rang-
ing from 1992 to 2012, the adopted 
scanning techniques were not the same 
and the US machines and probes were 
different because of the relevant tech-
nological advances made in the last 
twenty years. The criteria for the inclu-
sion of patients and even more the se-
lection of controls in case-control stud-
ies were very heterogeneous.
The features of the included studies are 
shown in Table II. Eight studies evalu-
ated shoulder US, 1 study hip US, and 
4 studies both. Four studies adopted 
a case-control design, 3 studies were 
prospective. The reference standard 
applied for diagnosis is reported for the 
studies for which sensitivity and spe-
cificity have been calculated; only ex-
pert opinion or recognised diagnostic 
criteria were used (35, 36). Tables III 
and IV report the prevalence of US ab-
normalities among cases and controls; 
the prevalence over the total number of 
cases and controls has been reported for 
all findings, and where they were not 
directly reported in the paper they were 
calculated by the reviewers, although 
not all papers reported sufficient data.
Two studies (28, 29) were not included 
in Table III, since there was insufficient 
data to evaluate the prevalence of sin-
gle findings. In a 1998 study, Lange and 
colleagues evaluated 13 PMR patients 
and 19 EORA controls. Patients with 
PMR had inflammatory involvement 
in articular and periarticular shoulder 
structures in 61.5% of cases, while 
EORA patients in 63.2%. The same 
authors in 2000 reported a prevalence 
of GH synovitis in 40.9% of PMR pa-
tients, compared to 65.5% in EORA 
patients.
When sensitivities and specificities of 
single findings, detected cross-section-
ally, of the primary studies were calcu-
lated (Fig. 2), we found that there was 
a great variability in their values, and 
the findings were not always consistent 
across studies. What seemed to emerge 
quite uniformly is that when single fea-
tures were taken into account, bilateral 
involvement tends to be more specific 
for a diagnosis of PMR.
Some studies evaluated the value of pro-
spective US evaluation in PMR, the fo-
cus of all of them being shoulder US.
In 2009 Macchioni evaluated 57 PMR 
patients for a 12-month period per-
forming shoulder US, examining SAD 
bursa, LHBT and GH joint. At the time 
of diagnosis, 98.2% of patients had in-
flammatory signs detected by US, and 
45.8% by power Doppler (PD) signal. 
After corticosteroid treatment, the only 
inflammatory sign that significantly and 
consistently decreased was SAD bursi-
tis. LHBT tenosynovitis and GH syno-
vitis were not less prevalent. However, 
the thickness of the examined structures 
decreased, together with the prevalence 
of PD. Moreover, a relevant proportion 
of patients that were in clinical remis-
sion showed US signs of involvement 
of extra-articular structures (30).
Jiménez-Palop prospectively followed 
59 PMR patients in order to investigate 
the sensitivity to change of shoulder 
and hip US after the beginning of cor-
ticosteroid treatment. The standardised 
response mean for US was similar to 
that of the main clinical and laboratory 
variables (27). 
One study used US for the follow-up 
of 6 corticosteroid-refractory PMR pa-
tients treated with etanercept. US dem-
onstrated a reduction of GH and peri-
articular inflammatory signs at the end 
of follow-up (21).
Fig. 1. Flow chart showing the selection process.
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A limited number of studies dealt with 
hip US, and in only one case, hip was 
the main focus of the paper (23). Table 
IV summarises the prevalence of US 
abnormalities at hip level in patients 
and controls, with a high proportion of 
PMR patients presenting with inflam-
matory signs at the hip. One of these 
studies provided data on follow-up 
(19) and, similarly to what happened to 
shoulder US, detectable abnormalities 
decreased along with main clinical and 
laboratory parameters.
Discussion
Since US has been introduced in the field 
of rheumatology, its application to rheu-
matological diseases, including PMR, 
has been wide. In particular, in patients 
with PMR, presenting with character-
istic symptoms, attention has been fo-
cused on the examination of girdles and 
shoulders in particular (31). The utility 
of US has been tested in particular for 
its potential to differentiate PMR from 
EORA or non-specific shoulder con-
ditions, but also the main differences 
between healthy subjects and PMR pa-
tients have been taken into account.
We adopted a comprehensive search 
strategy in order not to miss any rel-
evant study. The search terms were 
meant to include studies dealing with 
both PMR and EORA patients. Filters 
for specific study designs were not used, 
since we did not aim to include a single 
type of study. Due to the use of a sensi-
tive rather than specific search strategy, 
all relevant studies have probably been 
included.
When we examined the characteris-
tics of the studies that were included, a 
high degree of variability was evident. 
These studies were conducted over a 
long period, from the beginning of the 
nineties to 2012. The US equipment 
that was adopted was not uniform, and 
in some cases not described in detail. 
The criteria used to include patients 
were variable, and control groups were 
even more variable. In fact, control 
groups were made up of healthy sub-
jects, patients with non-specific shoul-
der conditions, patients with EORA or 
other rheumatic diseases, in different 
proportions. Even if heterogeneity has 
not been statistically tested, in its likely 
occurrence we decided not to summa-
rise data in a meta-analysis. Moreover, 
the number of studies included was 
limited and there was not sufficient 
data in all of them to make a 2x2 table, 
and these are further reasons that lim-
ited the synthesis of data.
When we evaluated the sensitivity and 
specificity of single US findings for the 
diagnosis of PMR in the limited number 
of studies that presented sufficient data, 
the differences across studies became 
even more evident. Taking single US 
abnormalities into account, the one that 
seemed to provide the best diagnostic 
accuracy is the presence of SAD bursi-
tis (monolateral or bilateral); the detec-
tion of a bilateral bursitis seemed to be 
the most specific finding in all studies. 
In general, when the alterations were bi-
lateral, higher values of specificity were 
reached, but with lower sensitivity. The 
amount of evidence that has accumu-
lated on this topic is greater for US ex-
amination of the shoulders, while only a 
minority of studies examined the hips. 
Only one study performed PD exami-
nation, however, the limited use of PD 
might be due to the low sensitivity of 
PD in these specific joints (37) and fu-
ture technological improvements might 
help to overcome this limitation.
Another field that might be further in-
vestigated is the potential use of US to 
monitor patients with PMR after the 
prescription of treatment. The studies 
that used US to examine patients with 
PMR after the beginning of treatment 
suggest a potential utility of US fol-
low-up.
When PMR classification criteria were 
developed and tested, the possible in-
Table III. Prevalence of shoulder US abnormalities. All numbers refer to the percentage of patients presenting a definite abnormality over 
the total number of cases or controls.
  Glenohumeral joint effusion Subacromial bursitis Biceps tendon tenosynovitis
 
 Total Monolateral Bilateral Total Monolateral Bilateral Total Monolateral Bilateral
 case  control case  control case  control case  control case  control case  control case  control case  control case  control
Balser 2012 34.6 - - - - - 46.2 - - - - - 92.3 - - - 80.8 -
Cantini 2001 (26) 66.6 - 33.3 - 33.3 - 94.4 - 0 - 94.4 - 72.2 - 22.2 - 50 -
Cantini 2001 (25) 77 58 42 20.1 35 32.4 96 22 3 21 93 0.87 80.6 53 22.8 49 57.8 3.5
Catanoso 2007 33.3 - 0 - 33.3 - 100 - 16.7 - 83.3 - 100 - 50 - 50 -
Coari 1999* 65.6 23 - - - - 9.4 10 - - - - 15 52 - - - -
Falsetti 2002 66 35 12 13 54 22 70 39 16 17 54 22 68 41 30 7 38 34
Jiménez-Palop 2010 18 - - - 18 - 65 - - - 65 - 45 - - - 45 -
Koski 1992 52 - 26 - 26 - 15 - 5.1 - 9.9 - 42 - 26.5 - 15.5 -
Macchioni 2009 - - 19.3 - 15.8 - - - 29.8 - 61.4 - - - 26.3 - 71.9 -
Ruta 2012** - - - - 3 10 - - - - 37 3 - - - - 30 0
* In this study joints and not patients are taken as a statistical unit. ** controls are RA patients.
 Coxofemoral joint effusion/synovitis Trochanteric bursitis
 
 Total Monolateral Bilateral Total Monolateral Bilateral
 
 case   control case  control case  control case  control case  control case  control 
Balser 2012 25.7 - 20 - - - - - - - - -
Cantini 2005 45 45 - - - - 100 30 - - 90 -
Falsetti 2002 40 - 8 - 32 - - - - - - -
Jiménez-Palop 2010 - - - - 30 - - - - - - -
Koski 1992 53 - - - - - - - - - - -
Table IV. Prevalence of hip US abnormalities. All numbers refer to the percentage of 
patients presenting a definite abnormality over the total number of cases and controls.
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clusion of US parameters was taken 
into consideration as a possible tool to 
improve their performance. However, 
probably due to the knowledge of some 
heterogeneity in the literature on this 
subject, the incorporation of US pa-
rameters in the final set of criteria was 
driven by a study specifically designed 
to test their accuracy (8). In this case, 
US alterations at shoulders or hips 
were tested in variable combinations. 
The diagnostic value of US has not 
been taken into account separately, but 
only in addition to the clinical features 
included in the final set. In the context 
of the new criteria, US is an optional 
instrument, however, in the validation 
of the criteria it has shown to improve 
their sensitivity.
The results of the present review seem 
to point to the very same conclusion. 
US abnormalities, especially at the 
level of the shoulders (bursitis and 
LHBT tenosynovitis in particular) and 
especially when bilateral, occur more 
frequently in patients with PMR com-
pared to controls. However, the finding 
of isolated US abnormalities, in the 
absence of suggestive clinical features, 
should not lead to a diagnosis of PMR. 
Based on this consideration, the main 
effort might now be that of testing the 
performance of the new classification 
criteria, examining the additive value 
of US, in an observational setting. In-
terestingly, two studies presented at the 
2012 ACR congress had already tested 
the new classification criteria, apply-
ing also US, proving the validity of the 
new criteria. However, in one study the 
addition of US proved to increase the 
performance of the criteria (38), while 
in the second one sensitivity was not 
increased (39).
The performance of the new criteria and 
US could be tested particularly in the 
settings in which differential diagno-
sis is more difficult, such as in EORA. 
A group of patients with rheumatoid 
arthritis has also been included in the 
validation cohort, but especially in this 
subgroup US seemed to be less helpful 
to distinguish cases and controls. The 
two studies included in this review that 
evaluated EORA control patients (21, 
26) failed to prove differences in shoul-
der US between cases and controls.
Despite these limitations, US has 
emerged as a useful tool to improve 
the management of patients with PMR. 
Moreover, its application might be ex-
tended in specific settings with more 
defined objectives.
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